SCHEMBL525893

SCHEMBL525893

N#C[CH]c1cccc(F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 9/20 0.58
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
PKM P14618 1/20 0.52
MAPK1 P28482 1/20 0.52
THPO P40225 1/20 0.52
NPC1 O15118 1/20 0.52
CHRM5 P08912 1/20 0.52
GRM5 P41594 1/20 0.52
RAB9A P51151 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
PTGS1 P23219 2/20 0.46
PTGS2 P35354 1/20 0.46
IKBKB O14920 1/20 0.44
FGFR1 P11362 1/20 0.44
NQO2 P16083 1/20 0.44
FBP1 P09467 1/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10546476 0.84 NFE2L2 (0.46) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL31350 0.79 NFE2L2 (0.65) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL22692 0.79 NFE2L2 (0.65) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL22693 0.79 NFE2L2 (0.65) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL3221530 0.78 NFE2L2 (0.58) NFE2L2CYP1A2CYP3A4CYP2D6PKM
SCHEMBL10543793 0.75 MAOA (0.40) NFE2L2CYP3A4MAPK1NPC1MAPT
SCHEMBL10547691 0.75 MAOA (0.40) NFE2L2CYP1A2CYP3A4MAPT
SCHEMBL10550570 0.75 ALDH1A1 (0.47) NFE2L2CYP1A2CYP3A4CYP2D6MAPK1
SCHEMBL10550056 0.74 SLC6A2 (0.39) NFE2L2NPC1RAB9APTGS1MAPT
SCHEMBL6382576 0.74 LCK (0.52) CYP3A4BLMFBP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015048547-A2 METHODS FOR USING AND BIOMARKERS FOR AMPK-ACTIVATING COMPOUNDS RIGEL PHARMACEUTICALS, INC. (US) 2015-04-02 WO disclosed
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO disclosed